Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.3M Buy
37,927
+725
+2% +$71.9K 0.76% 36
2026
Q1
$3.5M Buy
37,202
+1,075
+3% +$107K 0.67% 41
2025
Q4
$3.57M Buy
36,127
+746
+2% +$72.2K 0.67% 43
2025
Q3
$3M Sell
35,381
-735
-2% -$58.1K 0.59% 43
2025
Q2
$2.46M Sell
36,116
-14,115
-28% -$894K 0.6% 45
2025
Q1
$3.04M Buy
50,231
+780
+2% +$54.4K 0.73% 42
2024
Q4
$3.42M Buy
49,451
+1,511
+3% +$108K 0.79% 41
2024
Q3
$3.17M Buy
47,940
+3,272
+7% +$209K 0.73% 46
2024
Q2
$2.71M Buy
44,668
+7,769
+21% +$440K 0.67% 51
2024
Q1
$2.1M Buy
36,899
+7,783
+27% +$467K 0.52% 56
2023
Q4
$1.83M Sell
29,116
-24,472
-46% -$1.38M 0.48% 57
2023
Q3
$3.1M Buy
53,588
+953
+2% +$60.1K 0.9% 40
2023
Q2
$3.28M Sell
52,635
-3,527
-6% -$236K 0.9% 37
2023
Q1
$4.06M Sell
56,162
-220
-0.4% -$17.2K 1.21% 30
2022
Q4
$4.53M Buy
+56,382
New +$4.31M 1.4% 27

Other funds holding INCY

Legacy Trust's INCY Position: Q2 2026 in Review

Legacy Trust increased its Incyte (INCY) stake by 1.9% in Q2 2026, buying an estimated $71.9K and bringing the position to 37,927 shares worth $4.3M. The position accounts for 0.76% of the portfolio, ranked #36.

Legacy Trust first reported a position in INCY in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.53M in Q4 2022. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Legacy Trust held 37,927 shares of Incyte worth $4.3M as of Q2 2026.
  • Legacy Trust bought 725 Incyte shares in Q2 2026, an estimated $71.9K.
  • Incyte made up 0.76% of Legacy Trust's portfolio in Q2 2026, its #36 holding.
  • Legacy Trust first reported a position in Incyte in Q4 2022 and has held it in 15 quarters since.
  • Legacy Trust's Incyte position peaked at $4.53M in Q4 2022.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.